The present disclosure is directed to compositions and methods for the administration of a nutraceutical. The present disclosure is also directed to compositions and methods for the trafficking of stem cells.

The present disclosure is directed to compositions and methods for the administration of a nutraceutical. The present disclosure is also directed to compositions and methods for the trafficking of stem cells.

The invention relates to a human milk oligosaccharide (HMO) for use in, a synthetic composition comprising an HMO for use in and a method for preventing or treating migraine in a human.

The invention relates to a human milk oligosaccharide (HMO) for use in, a synthetic composition comprising an HMO for use in and a method for preventing or treating migraine in a human.

A health functional food product prepared by fermenting a dough containing whey, including a health functional bakery product prepared by: preparing a sponge and a dough by adding and mixing about 1.0 to 10 wt part of a whey powder and about 0.01 to 1.0 wt part of a mixture of probiotic preparation consisting of Leuconostoc strain, Lactobacillus strain and 2 kinds of Saccharomyces strains as to 100 wt part of a dough; and fermenting, aging and baking the dough. Such may be used to prepare a health functional bakery product as well as a health functional Lactobacillus fermented drink using said health functional bakery product.

Fermented milk products can provide multiple benefits. However, it was commonly believed that fermented milk products are not suitable for the administration to canids as e.g. dogs can be intolerant to lactose. The present invention provides fermented milk products for administration to canids.

Fermented milk products can provide multiple benefits. However, it was commonly believed that fermented milk products are not suitable for the administration to canids as e.g. dogs can be intolerant to lactose. The present invention provides fermented milk products for administration to canids.

The present invention provides a novel milk allergy antigen, a milk allergy diagnosis method or diagnosis kit, a composition comprising the antigen, a milk or processed milk product with the antigen removed, and a tester composition for determining the presence or absence of the milk antigen in an object of interest. The present invention also pertains to an antigen epitope-comprising polypeptide, a kit for diagnosing an allergy comprising the polypeptide, diagnostic composition, a diagnosis method, a composition comprising the polypeptide, and a raw material or processed product in which the polypeptide-comprising antigen is eliminated or reduced. The present invention further pertains to a tester composition for determining the presence or absence of an antigen in an object of interest.

The present invention provides a novel milk allergy antigen, a milk allergy diagnosis method or diagnosis kit, a composition comprising the antigen, a milk or processed milk product with the antigen removed, and a tester composition for determining the presence or absence of the milk antigen in an object of interest. The present invention also pertains to an antigen epitope-comprising polypeptide, a kit for diagnosing an allergy comprising the polypeptide, diagnostic composition, a diagnosis method, a composition comprising the polypeptide, and a raw material or processed product in which the polypeptide-comprising antigen is eliminated or reduced. The present invention further pertains to a tester composition for determining the presence or absence of an antigen in an object of interest.

An object of the present invention is to provide an enzyme-treated milk product, a method for preparing the same, a composition thereof comprising a pharmaceutical composition, and a product thereof comprising a pharmaceuticals. The enzyme-treated milk product can be obtained by a method for producing an enzyme-treated milk product including a step for bringing milk into contact with β-galactosidase.